(Q40810908)

23 September 2017

title

Control of cell cycle progression in human mesothelioma cells treated with gamma interferon (English)

1 reference

23 September 2017

0 references

Vivo C

1

1 reference

23 September 2017

Lévy F

2

1 reference

23 September 2017

Pilatte Y

3

1 reference

23 September 2017

Fleury-Feith J

4

1 reference

23 September 2017

Chrétien P

5

1 reference

23 September 2017

Monnet I

6

1 reference

23 September 2017

Kheuang L

7

1 reference

23 September 2017

Jaurand MC

8

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

23 September 2017

number of pages

9

1 reference

inferred from page(s)

published in

Oncogene

1 reference

23 September 2017

volume

20

1 reference

23 September 2017

issue

9

1 reference

23 September 2017

page(s)

1085-1093

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1204199

23 September 2017

exact match

0 references

cites work

Nuclear accumulation of interferon gamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Cellular responses to interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Chemosensitivity and cytokine sensitivity of malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

The role of growth factors and cytokines in the tumorigenesis and immunobiology of malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

A novel DNA damage checkpoint involving post-transcriptional regulation of cyclin A expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

CD40 ligation alters the cell cycle of differentiating keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

IFNgamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1/CIP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Interferon-gamma suppresses PDGF production from THP-1 cells and blood monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Genetic toxicity of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

A new model of cell cycle-regulated transcription: repression of the cyclin A promoter by CDF-1 and anti-repression by E2F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated repressor elements in multiple promoters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Interferon-gamma inhibits DNA synthesis and insulin-like growth factor-II expression in human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Differential expression of the p27Kip1 mRNA in IFN-sensitive and resistant cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

The European mesothelioma epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Transcriptional silencing of perlecan gene expression by interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Interferon-gamma-mediated inhibition of cyclin A gene transcription is independent of individual cis-acting elements in the cyclin A promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

The carboxyl terminus of interferon-gamma contains a functional polybasic nuclear localization sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

A role for the cyclin-dependent kinase inhibitor p21 in the G1 cell cycle arrest mediated by the type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

High levels of MDM2 are not correlated with the presence of wild-type p53 in human malignant mesothelioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

In vitro effects of recombinant human interferon gamma on human mesothelioma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: a Phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Potential for Interferon-α-Based Therapy in Mesothelioma: Assessment in a Murine Model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Effect of interferon-alpha 2a on malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Cytometry of cyclin proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

How does interferon exert its cell growth inhibitory effect?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Chromosomal changes induced by chrysotile fibres or benzo-3,4-pyrene in rat pleural mesothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Differential responsiveness of human and rat mesothelioma cell lines to recombinant interferon-gamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Proteolytic ratchets that control progression through mitosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Changes of cell cycle-regulating genes in interferon-treated Daudi cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204199

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204199

1 reference

Dimensions Publication ID

23 September 2017

1000384801

0 references

1 reference